BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28479419)

  • 1. Novel tumor-suppressor function of KLF4 in pediatric T-cell acute lymphoblastic leukemia.
    Shen Y; Chen TJ; Lacorazza HD
    Exp Hematol; 2017 Sep; 53():16-25. PubMed ID: 28479419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies.
    Cordo' V; van der Zwet JCG; Canté-Barrett K; Pieters R; Meijerink JPP
    Blood Cancer Discov; 2021 Jan; 2(1):19-31. PubMed ID: 34661151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncation- and motif-based pan-cancer analysis reveals tumor-suppressing kinases.
    Hudson AM; Stephenson NL; Li C; Trotter E; Fletcher AJ; Katona G; Bieniasz-Krzywiec P; Howell M; Wirth C; Furney S; Miller CJ; Brognard J
    Sci Signal; 2018 Apr; 11(526):. PubMed ID: 29666306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias.
    Delgado-Martin C; Meyer LK; Huang BJ; Shimano KA; Zinter MS; Nguyen JV; Smith GA; Taunton J; Winter SS; Roderick JR; Kelliher MA; Horton TM; Wood BL; Teachey DT; Hermiston ML
    Leukemia; 2017 Dec; 31(12):2568-2576. PubMed ID: 28484265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEF2C-dysregulated pediatric T-cell acute lymphoblastic leukemia is associated with CDKN1B deletions and a poor response to glucocorticoid therapy.
    Colomer-Lahiguera S; Pisecker M; König M; Nebral K; Pickl WF; Kauer MO; Haas OA; Ullmann R; Attarbaschi A; Dworzak MN; Strehl S
    Leuk Lymphoma; 2017 Dec; 58(12):2895-2904. PubMed ID: 28482719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLF4 represses MAP2K7 signaling in T-ALL.
    Lacorazza HD
    Oncotarget; 2017 Sep; 8(43):73366-73367. PubMed ID: 29088711
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation of the Side Population in Myc-induced T-cell Acute Lymphoblastic Leukemia in Zebrafish.
    Pruitt MM; Marin W; Waarts MR; de Jong JLO
    J Vis Exp; 2017 May; (123):. PubMed ID: 28518092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric precursor B acute lymphoblastic leukemia: are T helper cells the missing link in the infectious etiology theory?
    Bürgler S; Nadal D
    Mol Cell Pediatr; 2017 Dec; 4(1):6. PubMed ID: 28508352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tumor-associated splice-isoform of
    Ray D; Yun YC; Idris M; Cheng S; Boot A; Iain TBH; Rozen SG; Tan P; Epstein DM
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16391-16400. PubMed ID: 32601196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLF4 and CD55 expression and function depend on each other.
    An FQ; Zhou G; Harland MT; Hussain W; Strainic MG; Jain MK; Medof ME
    Front Immunol; 2023; 14():1290684. PubMed ID: 38406578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer.
    Zeng Z; Fu M; Hu Y; Wei Y; Wei X; Luo M
    Mol Cancer; 2023 Oct; 22(1):172. PubMed ID: 37853437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational Design of Highly Potent and Selective Covalent MAP2K7 Inhibitors.
    Kim DR; Orr MJ; Kwong AJ; Deibler KK; Munshi HH; Bridges CS; Chen TJ; Zhang X; Lacorazza HD; Scheidt KA
    ACS Med Chem Lett; 2023 May; 14(5):606-613. PubMed ID: 37197477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLF4 transcription factor in tumorigenesis.
    He Z; He J; Xie K
    Cell Death Discov; 2023 Apr; 9(1):118. PubMed ID: 37031197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent epigenetic alterations in transcription factors after a sustained virological response in hepatocellular carcinoma.
    Sugimachi K; Araki H; Saito H; Masuda T; Miura F; Inoue K; Shimagaki T; Mano Y; Iguchi T; Morita M; Toh Y; Yoshizumi T; Ito T; Mimori K
    JGH Open; 2022 Dec; 6(12):854-863. PubMed ID: 36514506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Signature of N
    Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
    Front Immunol; 2022; 13():809872. PubMed ID: 35185897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the MAP2K7-JNK pathway with 5Z-7-oxozeaenol induces apoptosis in T-cell acute lymphoblastic leukemia.
    Chen TJ; Du W; Junco JJ; Bridges CS; Shen Y; Puppi M; Rabin KR; Lacorazza HD
    Oncotarget; 2021 Aug; 12(18):1787-1801. PubMed ID: 34504651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of consistent post-translational regulatory triplets related to oncogenic and tumour suppressive modulators in childhood acute lymphoblastic leukemia.
    Wee Y; Liu Y; Zhao M
    PeerJ; 2021; 9():e11803. PubMed ID: 34316412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL.
    Liu WH; Mrozek-Gorska P; Wirth AK; Herold T; Schwarzkopf L; Pich D; Völse K; Melo-Narváez MC; Carlet M; Hammerschmidt W; Jeremias I
    Biomark Res; 2020; 8():46. PubMed ID: 32944247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic profiling of MUTYH, KLF6, WNT1 and KLF4 genes in carcinogenesis and tumorigenesis of colorectal cancer.
    Babaei K; Khaksar R; Zeinali T; Hemmati H; Bandegi A; Samidoust P; Ashoobi MT; Hashemian H; Delpasand K; Talebinasab F; Naebi H; Mirpour SH; Keymoradzadeh A; Norollahi SE
    Biomedicine (Taipei); 2019 Dec; 9(4):22. PubMed ID: 31724937
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.